Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling

Sponsor
Medical College of Wisconsin (Other)
Overall Status
Completed
CT.gov ID
NCT00677508
Collaborator
Takeda Pharmaceuticals North America, Inc. (Industry), University of South Alabama (Other), Boston Children's Hospital (Other), Ohio State University (Other), University of Texas Southwestern Medical Center (Other)
140
1
71
2

Study Details

Study Description

Brief Summary

We propose to develop parent and child disease-specific instruments to assess health related quality of life (HRQoL) in children with constipation and fecal incontinence.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Chronic constipation is a common problem in childhood, accounting for almost 3% of consultations in pediatric practice. In many children constipation is accompanied by overflow soiling (fecal incontinence). This condition often gives rise to behavioral, social, and emotional problems.

    We plan to develop a disease-specific instrument to assess HRQoL in children with constipation and fecal incontinence. We hypothesize that HRQoL is worse in children with fecal incontinence compared to children with constipation but no fecal incontinence. The instrument will involve both parent and child self-reporting measures and will enable researchers to evaluate how disease and treatment strategies impact both child and parent perceptions of quality of life. In the long run this will enable physicians to develop a child friendly approach to management of chronic constipation and fecal incontinence.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    140 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
    Actual Study Start Date :
    Sep 1, 2005
    Actual Primary Completion Date :
    Aug 1, 2011
    Actual Study Completion Date :
    Aug 1, 2011

    Arms and Interventions

    Arm Intervention/Treatment
    C FR

    Children with constipation and fecal incontinence.

    C

    Children with constipation but without fecal incontinence.

    P-C FR

    Parents of children with constipation and/or fecal incontinence.

    Outcome Measures

    Primary Outcome Measures

    1. To develop and validate child and parent questionnaires to assess HRQoL of children with chronic constipation and fecal incontinence. [2 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    2 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion criteria:
    1. Age 2-18 years

    2. Child and parents fluent in English

    3. Child must meet one of the following criteria;

    1. Constipation and fecal incontinence: must include 2 or more of the following in a child with insufficient criteria for a diagnosis of IBS (criteria fulfilled at least once per week for at least 2 months before diagnosis in a child over 4 years of age and for at least one month in a child less than 4 years of age):
    1. Two or fewer defecations in the toilet per week

    2. At least 1 episode of fecal incontinence per week

    3. History of retentive posturing or excessive volitional stool retention

    4. History of painful or hard bowel movements

    5. Presence of a large fecal mass in the rectum

    6. History of large diameter stools that may obstruct the toilet

    1. Constipation predominant IBS: must include the following, once a week for at least 2 months:
    1. Abdominal pain/discomfort, associated with 2 of the following:
    • improved with defecation

    • onset associated with 2 or less stools per week

    • onset associated with hard or lump stool

    1. no evidence of inflammatory, anatomic, metabolic or neoplastic processes.
    1. Non retentive fecal incontinence: must include all of the following in a child with a developmental age of at least 4 years (criteria fulfilled at least once per week for at least 2 months before diagnosis) [4]:
    1. Defecation into places inappropriate to the social context at least once per month.

    2. No evidence of an inflammatory, anatomic, metabolic, or neoplastic process that explains the subject's symptoms

    3. No evidence of fecal retention.

    Exclusion criteria:
    1. Children with developmental delays and children over 12 years of age who are unable to understand the questionnaires.

    2. Associated chronic disease which may have an impact on quality of life such as cerebral palsy, spine deformity or malformations, learning difficulties, severe mental illness, celiac disease, etc.

    3. Child and parents not fluent in English.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Medical College of Wisconsin Milwaukee Wisconsin United States 53226

    Sponsors and Collaborators

    • Medical College of Wisconsin
    • Takeda Pharmaceuticals North America, Inc.
    • University of South Alabama
    • Boston Children's Hospital
    • Ohio State University
    • University of Texas Southwestern Medical Center

    Investigators

    • Principal Investigator: Manu Sood, MD, Medical College of Wisconsin

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Manu Sood, Chief, Associate Professor, Medical College of Wisconsin
    ClinicalTrials.gov Identifier:
    NCT00677508
    Other Study ID Numbers:
    • CHW 05/154
    First Posted:
    May 14, 2008
    Last Update Posted:
    Apr 30, 2020
    Last Verified:
    Apr 1, 2020
    Keywords provided by Manu Sood, Chief, Associate Professor, Medical College of Wisconsin
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 30, 2020